Zynquista
sotagliflozin
Diabetes Mellitus, Type 1
Date of authorisation:
Revision: 3
Last updated:
MedicineHumanWithdrawn
EMEA-001517-PIP02-14-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/0226/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Granules
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001201-PIP01-11-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0229/2013
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Hexavac
diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted
Hepatitis B
Tetanus
Immunization
Meningitis, Haemophilus
Whooping Cough
Poliomyelitis
Diphtheria
Date of authorisation:
Last updated:
MedicineHumanWithdrawn
EMEA-000394-PIP01-08-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0034/2012
Route(s) of administration: Intramuscular route
Pharmaceutical form(s):
Suspension for injection
Suspension for injection in pre-filled syringe
Decision date:
Last updated:
Compliance check: ✔
PIPHuman